Salerno Pharmaceuticals

Brooksville, United States Founded: 2006 • Age: 20 yrs Acquired By The Courtney Group
Pharmaceuticals for cholesterol treatment are developed by Salerno Pharmaceuticals.

About Salerno Pharmaceuticals

Salerno Pharmaceuticals is a Healthcare company based in Brooksville (United States) founded in 2006, and was acquired by The Courtney Group in June 2016. Pharmaceuticals for cholesterol treatment are developed by Salerno Pharmaceuticals. Salerno Pharmaceuticals offers products and services including FloLipid. Its focus areas include Life Sciences, Obesity and Drugs. Its competitors include Altimmune, Carmot and BioAge Labs; 3 of its 3 listed competitors have raised funding.

Company details

Salerno Pharmaceuticals was founded in 2006 and is headquartered in Brooksville, United States. Focus is placed on the development of cholesterol-treatment pharmaceuticals within the healthcare sector. Operations center on creating medications that address elevated cholesterol levels. The lead product, FloLipida liquid simvastatin formulationis employed as the initial liquid statin option. Risks of stroke, heart attack, and related cardiovascular issues are reduced through cholesterol level management facilitated by this product.

Operational Areas
Key Metrics

Products & Services of Salerno Pharmaceuticals

Salerno Pharmaceuticals offers a comprehensive portfolio of products and services, including FloLipid.

FloLipid
Cholesterol Medication

Liquid simvastatin to treat high cholesterol and lower heart disease risks.

Investors in Salerno Pharmaceuticals

Salerno Pharmaceuticals has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include The Courtney Group.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Investment banking and private equity services are provided by The Courtney Group.
thecourtneygroup.comNewport Beach, United States
Premium access

Investor details for Salerno Pharmaceuticals

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Salerno Pharmaceuticals

2 dated milestones of Salerno Pharmaceuticals across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded Salerno Pharmaceuticals is founded.
  2. Exit Acquired by The Courtney Group.

Competitors of Salerno Pharmaceuticals

Salerno Pharmaceuticals has 3 listed competitors in our database, 3 of them funded. They include Altimmune, Carmot and BioAge Labs.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
altimmune.com1997Gaithersburg, United States$58M17
Vaccines for infectious diseases and solid tumors are developed.
carmot.us2008Berkeley, United States$385.52M
Disease-modifying therapies for metabolic diseases are developed.
bioagelabs.com2015Vallejo, United States$293.9M43
Bioinformatics platform is provided for biomarkers and drug discovery.
Premium access

Detailed competitors of Salerno Pharmaceuticals

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Salerno Pharmaceuticals

The website of Salerno Pharmaceuticals (salernopharma.com) receives about 2.6K visits a month.

  • Monthly visits
    2.6K

    ▲ 63.4% vs previous month

Top companies in Obesity

3 companies that operate in the same segment as Salerno Pharmaceuticals (Obesity) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Satiety induction through digestable gastric balloon introduced via a swallowed capsule
2009Wellesley, Massachusetts, United StatesUSD 174.04 MUSD 32.11 M137
Bioinformatics platform is provided for biomarkers and drug discovery.
2015Vallejo, California, United StatesUSD 293.9 MUSD 8.99 M64
Disease-modifying therapies for metabolic diseases are developed.
2008Berkeley, California, United StatesUSD 385.52 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Salerno Pharmaceuticals

Salerno Pharmaceuticals was founded in 2006.

Salerno Pharmaceuticals is headquartered in Brooksville, United States. It is registered at Brooksville, Florida, United States.

Salerno Pharmaceuticals was founded in 2006 and is headquartered in Brooksville, United States. Focus is placed on the development of cholesterol-treatment pharmaceuticals within the healthcare sector. Operations center on creating medications that address elevated cholesterol levels. The lead product, FloLipida liquid simvastatin formulationis employed as the initial liquid statin option. Risks of stroke, heart attack, and related cardiovascular issues are reduced through cholesterol level management facilitated by this product.

Salerno Pharmaceuticals's top competitors include BioAge Labs, Carmot and Altimmune.

Salerno Pharmaceuticals offers FloLipid.

Salerno Pharmaceuticals has 1 investor. Key investors include The Courtney Group.

Salerno Pharmaceuticals operates through Salerno Pharmaceuticals.

Yes. Salerno Pharmaceuticals was acquired by The Courtney Group in June 2016.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available